Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hadley Lab is a clinical AI research and precision medicine company based in San Francisco, dedicated to translating big data into governed clinical intelligence. The company's flagship product, MammoChat, is a free, evidence-based AI platform for breast health that is currently being validated in a live clinical trial (NCT06604078). Hadley Lab utilizes its proprietary 'MAGIC 255' governance engine and 'The Machine' platform to ensure that its suite of AI tools—including CaribChat for regional oncology—provides transparent, sourced, and auditable medical insights. By integrating genomics, deep learning, and blockchain technology, the lab aims to improve disease screening, diagnosis, and management while maintaining strict data privacy and patient agency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hadley.